Pharmacokinetics, Safety, and Tolerability of Flosequinan in Patients with Hepatic Dysfunction
Open Access
- 1 March 1994
- journal article
- clinical trial
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 83 (3) , 382-385
- https://doi.org/10.1002/jps.2600830323
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Pharmacology of flosequinanAmerican Heart Journal, 1991
- Central and regional hemodynamic effects of flosequinan for congestive heart failureThe American Journal of Cardiology, 1989
- The effect of flosequinan in patients with acute-onset heart failure complicating acute myocardial infarction.Japanese Heart Journal, 1989
- Simplified high-performance liquid chromatographic determination of flosequinan and its metabolite in plasma, serum and urineJournal of Chromatography B: Biomedical Sciences and Applications, 1988
- Flosequinan in heart failure: acute haemodynamic and longer term symptomatic effects.BMJ, 1988
- Cumulative Hemodynamic Response to Short-Term Treatment with Flosequinan (BTS 49465), a New Direct-Acting Vasodilator Drug, in Severe Chronic Congestive Heart FailureJournal of Cardiovascular Pharmacology, 1988
- Hemodynamic effects of BTS 49465, a new long-acting systemic vasodilator drug, in patients with severe congestive heart failureAmerican Heart Journal, 1987